PDS Biotechnology Corp
PDSB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001472091
No open-market purchases or sales by PDS Biotechnology Corp insiders were filed in the last 90 days; 52 institutions reported holding it in 13F filings for Q2 2026, worth $6.78M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding PDS Biotechnology Corp changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 57 | 1 | 52 | −4 |
| Shares | 4.34M | 11.7K | 4.25M | −74.3K (−1.7%) |
| Value | $16.6M | $44.8K | $6.94M | −$9.59M (−58.0%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held PDS Biotechnology Corp at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 54,693 | $89.0K | 0.00% |
| Jane Street Group, LLC | 35,644 | $58.1K | 0.00% |
| Raymond James Financial Inc | 15,865 | $25.9K | 0.00% |
| Burns J W & Co Inc | 10,300 | $16.8K | 0.00% |
| Bessemer Group Inc | 1,146 | $2.00K | 0.00% |
| R Squared Ltd | 300 | $489 | 0.00% |
| Caitong International Asset Management Co., Ltd | 247 | $403 | 0.00% |
| SBI Securities Co., Ltd. | 106 | $173 | 0.00% |
Sold out (12)
Institutions that held PDS Biotechnology Corp at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Amussen Hunsaker Associates LLC | 75,016 | $286.6K |
| Point72 Asia (Singapore) Pte. Ltd. | 22,426 | $85.7K |
| Cubist Systematic Strategies, LLC | 18,195 | $69.5K |
| Qube Research & Technologies Ltd | 15,673 | $59.9K |
| Invesco Ltd. | 13,815 | $52.8K |
| Charles Schwab Investment Management Inc | 13,278 | $50.7K |
| Lazari Capital Management, Inc. | 13,000 | $49.7K |
| LPL Financial LLC | 10,412 | $39.8K |
| Catalyst Funds Management Pty Ltd | 5,600 | $21.4K |
| Point72 (DIFC) Ltd | 50 | $191 |
| Farther Finance Advisors, LLC | 36 | $138 |
| Nisa Investment Advisors, LLC | 18 | $69 |
Not filed for Q4 2024 yet (1)
Institutions that held PDS Biotechnology Corp at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Raymond James & Associates | 11,731 | $44.8K |